AI assistant
Sending…
SILICON LABORATORIES INC. — Director's Dealing 2014
Mar 11, 2014
31118_dirs_2014-03-11_7b6a8a7d-22dc-45e9-b9df-c79983adf827.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SILICON LABORATORIES INC (SLAB)
CIK: 0001038074
Period of Report: 2014-03-07
Reporting Person: BOCK WILLIAM G (Director, President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-07 | Common Stock, $0.0001 par value | M | 12791 | $32.98 | Acquired | 96336 | Direct |
| 2014-03-07 | Common Stock, $0.0001 par value | S | 12791 | $53.0002 | Disposed | 83545 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-07 | Non-qualified Stock Option (right to buy) | $32.98 | M | 12791 | Disposed | 2016-11-08 | Common Stock, $0.0001 par value (12791) | Direct |
Footnotes
F1: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan.
F2: Price represents the weighted average selling price. Prices range between $53.00 and $53.005.
F3: Option vests and becomes exercisable with respect to (i) twenty percent (20%) of the option shares upon the date exercisable and (ii) the balance of the option shares in a series of forty-eight (48) successive monthly installments over the forty-eight (48) month period measured from the date exercisable.
F4: Not applicable per instruction 4(c)(iii).
More from SILICON LABORATORIES INC.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Annual Report
2026
Feb 10
Regulatory Filings
2026
Feb 4